Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07272473 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Cervical Mobilization on Dizziness, Balance, and Joint Position Sense in Patients With Meniere's Disease

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 48 participants (planned 33) · Primary completion date changed from estimate of Mar 30, 2026 to Jul 23, 2026 · Eligibility criteria expanded, about 13 words · 3 more Show 6 more changesShow less
    • Final enrollment: 48 participants (planned 33)
    • Primary completion date changed from estimate of Mar 30, 2026 to Jul 23, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 5 of 5 entries
    • Site details revised
    • Study description expanded, about 3 words
  2. Primary endpoints: 2 to 1 Interventions: vestibular rehabilitation (Other), vestibular rehabilitation and servical mobilization (Other) to Vestibular Rehabilitation + Cervical Mobilization (Other), vestibular rehabilitation (Other) · Eligibility criteria shortened, about 12 words · Secondary endpoints: details revised at 5 of 5 entriesv2 Show 3 more changesShow less
    • Interventions: vestibular rehabilitation (Other), vestibular rehabilitation and servical mobilization (Other) to Vestibular Rehabilitation + Cervical Mobilization (Other), vestibular rehabilitation (Other)
    • Eligibility criteria shortened, about 12 words
    • Secondary endpoints: details revised at 5 of 5 entries

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will employ a stratified randomization method. Patients presenting to the Afyonkarahisar Health Sciences University Health Application and Research Center, Ear, Nose, and Throat Outpatient Clinic, with a definitive diagnosis of Meniere's disease, unilateral or bilateral involvement, and who consent to participate in the study will be divided into three groups. The control group will receive only their routine Betahistine. Their usual treatment will remain unchanged. The first study group will receive 20 minutes of Vestibular Rehabilitation (VR) and 10 minutes of cervical mobilization in addition to their routine Betahistine. The second study group will receive 30 minutes of VR in addition to Betahistine. The study will last 6 weeks. Participants will be assessed using a sociodemographic information questionnaire, the Dizziness Handicap Inventory (DHI), the Vertigo Symptom Scale (VSS), the Neck Disability Index (NDI), the International Tinnitus Inventory (ITI), balance assessment with the K-Force Plates, and joint position sense and proprioception assessment with the Kinvent Physio K-Move. All assessments will be conducted twice, before and after treatment.
Trial Details
NCT Number NCT07272473
Lead Sponsor Abant Izzet Baysal University
Conditions Meniere Disease
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov